Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Organisation › Details

vivoPharm Pty Ltd.

vivoPharm is a growing and profitable technology leader and innovator in preclinical in vivo oncology and other research services. It has developed more than 70 fully characterized and validated cancer cell lines used in oncology pharmaceutical research. vivoPharm has pioneered the development of proprietary orthotopic methods (site-specific grafting of tissues) and other specialized in vivo tumor models. vivoPharm has developed an expanding global base of customers both in the pharmaceutical and emerging biotech sectors. The Company is led by Dr. Ralf Brandt, a recognized cancer biologist, who, prior to founding vivoPharm, was Head of Tumor Biology at Novartis AG. *

 

Period Start 2015-03-31 existent
  Group vivoPharm (Group)
Product Industry  oncology
Person Person Brandt, Ralf (vivoPharma 201504 CEO + Founder before Head of Tumor Biology at Novartis AG)
     
  City n. a. Adelaide SA
    Address record changed: 2016-03-31
     
Basic data Employees n. a.
     
    * Document for �About Section�: Protea Biosciences Group, Inc.. (4/7/15). "Press Release: Protea Announces Agreement to Acquire vivoPharm". Morgantown, WV.
     
   
Record changed: 2016-03-31

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for vivoPharm (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px




» top